Literature DB >> 8335894

Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.

N Suzuki1, T Harada, Y Mizushima, T Sakane.   

Abstract

Extensive studies in murine models of lupus nephritis have shown that cationic anti-DNA autoantibodies have nephritogenic potential. We have investigated whether cationic anti-DNA antibodies of IgG class are also produced in vivo in patients with active lupus nephritis. Antibodies against DNA in the sera from patients with SLE were purified by affinity chromatography on DNA-cellulose, followed by nonequilibrium pH gradient electrophoresis and SDS-PAGE. The highly cationic anti-DNA antibodies of IgG class were prominent in the nonequilibrium pH gradient electrophoresis-immunoblots of the antibodies from the patients with active lupus nephritis. Decreased proteinuria after successful treatment with prednisolone was associated with disappearance of the cationic anti-DNA antibodies in the circulation. The cationic anti-DNA antibodies did bind to heparan sulfate, which is a major glycosaminoglycan in glomerular basement membrane, much better than did neutral anti-DNA antibodies. The results suggest that the cationic anti-DNA autoantibodies may play a certain role in the development of lupus nephritis. Our study demonstrates the strong association between the presence of cationic anti-DNA antibody and the development of lupus nephritis in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 2.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

3.  Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.

Authors:  N Suzuki; T Harada; S Mihara; T Sakane
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

4.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

5.  Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations.

Authors:  F Silvestris; P Cafforio; F Dammacco
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus.

Authors:  Elayne Pereira; Márcia Cristina Tamia-Ferreira; Renato Sousa Cardoso; Stephano Spanó Mello; Elza Tiemi Sakamoto-Hojo; Geraldo A S Passos; Eduardo Antonio Donadi
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

7.  Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.

Authors:  G Zhou; K Fujio; A Sadakata; A Okamoto; R Yu; K Yamamoto
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

8.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

Authors:  A Desai-Mehta; L Lu; R Ramsey-Goldman; S K Datta
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

9.  DNase1 activity in systemic lupus erythematosus patients with and without nephropathy.

Authors:  Fernando Martinez-Valle; Eva Balada; Josep Ordi-Ros; Segundo Bujan-Rivas; Agustin Sellas-Fernandez; Miquel Vilardell-Tarres
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

10.  Electric charge and sugar chains of immunoglobulin G in systemic lupus erythematosus.

Authors:  Koji Kinoshita; Sinya Ikoma; Toshiaki Yamagata; Yuji Nozaki; Masafumi Sugiyama; Masanori Funauchi
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.